SCHEMBL718222

SCHEMBL718222

[c]1[nH]c2ccccc2c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
HPGD P15428 5/20 0.41
KDM4E B2RXH2 5/20 0.41
ESR1 P03372 3/20 0.41
ESR2 Q92731 3/20 0.41
GAA P10253 2/20 0.41
ALPL P05186 1/20 0.41
IDO1 P14902 1/20 0.41
TTK P33981 1/20 0.41
MAPK10 P53779 1/20 0.41
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
EGFR P00533 1/20 0.37
HSD17B10 Q99714 3/20 0.37
GPR3 P46089 1/20 0.37
TP53 P04637 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
CYP19A1 P11511 1/20 0.36
CTSV O60911 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16935295 0.84 ALDH1A1 (0.39) ALDH1A1HPGDKDM4EESR1ESR2
SCHEMBL1879217 0.84 NR4A2 (0.47) ALDH1A1KDM4EGAAHTTSMN1; SMN2
SCHEMBL6992376 0.84 ESR1 (0.47) ALDH1A1HPGDESR1ESR2GAA
SCHEMBL6721218 0.84 IMPDH2 (0.47) ALDH1A1HPGDKDM4EIDO1MAPK1
SCHEMBL14977497 0.84 HSD17B10 (0.40) ALDH1A1HPGDKDM4EGAASMN1; SMN2
SCHEMBL7781750 0.77 HTR2B (0.42) ESR1ESR2MAPK10CYP19A1TUBB4A
SCHEMBL15283206 0.77 MEN1 (0.47) ALDH1A1HPGDKDM4EMAPK1SMN1; SMN2
SCHEMBL27685767 0.77 CDK4 (0.40) ALDH1A1HPGDKDM4EGAAMAPK1
SCHEMBL4389405 0.76 AKT2 (0.47) EGFRTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL4309887 0.74 PARP1 (0.36) ALDH1A1HPGDKDM4EGAAIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118027085-A Organic electroluminescent compound and application thereof 宁波卢米蓝新材料有限公司 2024-05-14 CN claimed
CN-112142644-A Method for preparing pearl bleaching agent phenyl indolyl selenium sulfone compound 浙江农林大学暨阳学院 2020-12-29 CN claimed
EP-2431444-B1 THERMOCHROMIC COLOR-MEMORY COMPOSITION, AND THERMOCHROMIC COLOR-MEMORY MICROCAPSULE PIGMENT HAVING THE COMPOSITION ENCAPSULATED THEREIN PILOT INK CO LTD (JP) 2019-11-13 EP claimed
EP-2873708-B1 Adhesive composition ARTIMELT AG (CH) 2019-02-13 EP claimed
US-9939747-B2 Developing agent and method for producing the same TOSHIBA TEC KABUSHIKI KAISHA (JP) 2018-04-10 US claimed
US-9644117-B2 Adhesive composition ARTIMELT AG (CH) 2017-05-09 US claimed
US-20170038698-A1 DEVELOPING AGENT AND METHOD FOR PRODUCING THE SAME TOSHIBA TEC KABUSHIKI KAISHA (JP) 2017-02-09 US claimed
US-20160289508-A1 ADHESIVE COMPOSITION ARTIMELT AG (CH) 2016-10-06 US claimed
WO-2015074953-A1 ADHESIVE COMPOSITION COLLANO ADHESIVES AG (CH) 2015-05-28 WO claimed
EP-2873708-A1 Adhesive composition Collano Adhesives AG (CH) 2015-05-20 EP claimed
US-7524878-B2 Phenyl substituted carboxylic acids THE INSTITUTE FOR PHARMACEUTICALS DISCOVERY LLC (US) 2009-04-28 US claimed
US-7476690-B2 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2009-01-13 US claimed
US-20060241119-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2006-10-26 US claimed
US-20050282821-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2005-12-22 US claimed
EP-1589016-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2005-10-26 EP claimed
US-6670053-B2 Employing interlayer comprising compound containing 3-phenylindolyl group between hole transport layer and light emitting layer EASTMAN KODAK COMPANY 2003-12-30 US claimed
US-20030180573-A1 Organic electroluminescent devices with high luminance EASTMAN KODAK COMPANY 2003-09-25 US claimed
EP-1339264-A2 Organic electroluminescent devices with high luminance EASTMAN KODAK COMPANY (US) 2003-08-27 EP claimed
CN-1378447-A Use of cell membrane penetrating indigoid bisindole derivatives FIEBIG HEINZ HERBERT (DE) 2002-11-06 CN claimed
WO-1991005786-A1 METHANOCYCLOOCTA[1,2-c;5,6-c']DIPYRIDINE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND MEDICAMENTS CONTAINING THEM KNOLL AKTIENGESELLSCHAFT (DE) 1991-05-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282821-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives HTR1A, HTR2A, HTR5A ALDH1A1 2457/4885HPGD 3681/4885KDM4E 1472/4885
US-20060241119-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives HTR1A, HTR2A, HTR5A ALDH1A1 2457/4885HPGD 3681/4885KDM4E 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.